Category English

WHO Members Negotiate Resolution On Cancer; High Prices In Question

Cancer is spreading. According to the World Health Organization, the number of new cases of cancer is projected to increase to 21.6 million annually by 2030. The WHO Executive Board this week is considering a draft resolution for actions by the WHO member states and the secretariat. The resolution is being discussed and amended as issues such as the affordability and the accessibility of new cancer medicines, in particular in developing countries, are highlighted by many.

Is Gates Foundation, WHO’s Biggest Private Funder, Ineligible To Join WHO?

As the World Health Organization Board prepares to consider candidate institutions to be admitted into official relations with the organisation, some health and public interest groups are raising alarm at what they see as a seeming lack of safeguard against conflicts of interest. Particular concern has been raised over admitting the Bill & Melinda Gates Foundation as an observer because of the Foundation trust’s investments in business ventures such as Coca-Cola, which they see as contrary to health goals. But the Gates Foundation, which is the biggest private donor to the WHO, said the trust is a separate entity from the foundation, and therefore does not represent any conflict of interest.

Antimicrobial Resistance At WHO: Accelerating National Plans, Ensuring Accessibility

The rising threat of “super bugs,” bacteria resistant to existing antibiotics, was in discussion at the World Health Organization this week. Concerns were voiced about the slow pace of national action plan implementation to improve the careful use of antibiotics. Meanwhile some developing countries and civil society called for priority to be given to accessibility and affordability to new antibiotics.

WHO Fine-Tunes Work On Epidemics In Debates On IHRs, R&D Blueprint

The Ebola outbreak spurred actions from the World Health Organization in terms of how to deal with emergencies and also getting medicines and vaccines to patients in emergency situations. The secretariat presented an implementation plan for the International Health Regulations, and a report on its recent blueprint on research and development for potentially epidemic diseases at its Executive Board meeting this week. The United States sought to limit the scope of WHO's work on R&D in this context.

US Could Agree To Slight Funding Increase At WHO Despite Trump Threats

President Donald Trump’s promise to cut US funding to United Nations agencies has sent shock waves around the UN, but in a budget discussion at the World Health Organization Executive Board meeting today, the US delegation did not reject outright a call by WHO to increase government contributions to the organisation. Meanwhile, the WHO budget shows a deficit and many WHO members asked the WHO how it plans to remedy the situation and find solutions to reach financial sustainability.

WHO Director Candidates Down To Three, Europe Drops In Ranking

The number of candidates to be the next director general of the World Health Organization was reduced from five to three tonight, with Ethiopia, Pakistan and the United Kingdom still in the running. But in a race as unpredictable as this one, delegates and observers in the hallway were both surprised and not surprised by the outcome as Europe fell to the bottom of the list.

Year Ahead: Copyright Issues Rank High On EU To-Do List This Year

Copyright, copyright and more copyright tops Europe's intellectual property agenda for 2017. With the EU institutions mulling major reforms to copyright laws, publishers are pushing for a right to bar unauthorised copying or reuse of their content for commercial purposes, audiovisual authors for fair remuneration for use of their works on platforms like YouTube. The European Commission will begin reviewing the enforcement of IP rights as well as delving further into issues related to liability of platforms for infringement. But there are many patent issues too, including plant variety protection, patent incentives, and the ongoing unitary patent court.